Kenya Faces Snakebite Crisis Amid Antivenom Shortages

Kenya faces a severe shortage of snake antivenom, leaving many victims, including children, at risk of amputation, disability, or death after snakebites. Hospitals are often far from affected communities, and the high cost and limited supply of antivenom—along with imported antivenoms that may be less effective due to regional venom differences—mean many cannot access or afford lifesaving treatment. As a result, some victims turn to traditional remedies, such as the 'snake stone,' rooted in local beliefs and seen as more accessible, despite the risk of dangerous delays in receiving proper care. Experts warn that reliance on these practices contributes to underreported cases and worsens outcomes, with the World Health Organization estimating that up to 138,000 people die from snakebites globally each year. The situation is exacerbated by myths, the high price of antivenom, and the need for multiple costly doses in severe cases, pushing families into financial hardship. Calls are growing for improved local production, distribution, and affordability of antivenom to address these preventable tragedies.